BioMarin Pharmaceutical Inc. - Common Stock — Cash Flow (NASDAQ:BMRN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 85.36 M304.54 M175.9 M159.26 M572.84 M827.99 M 874.25 M Cash from investing activities -53.62 M-366.31 M-20.03 M-111.24 M136.49 M-414.24 M 339.52 M Cash from financing activities 181.12 M-48 K-18.65 M-18.73 M-526.45 M-42.39 M 809.55 M Free cash flow 85.36 M304.54 M175.9 M159.26 M572.84 M827.99 M 874.25 M

News

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo

BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth

Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead

BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts

Ascendis Pharma Stock: Behind The Stock Surge (NASDAQ:ASND)

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?

BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

BMRN Stock Down on Mixed Results From Rare Disease Therapy Study

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised